The listing follows a private placement conducted between December 5 and December 11, 2025, through which the company attracted RON 5.23 million (around €1 million) from investors. IT Genetics is the first company to list on the BVB by leveraging non-reimbursable funds through the National Recovery and Resilience Plan (PNRR), specifically designed to support the costs associated with the listing process.

Following the private placement, 80 investors subscribed to 748,341 shares, with the free-float segment representing 12.23% of the total number of shares. At the share sale price of RON 7/share, the company's market capitalisation stands at RON 42.82 million (€8.2 million).

"Through Component 9 of the PNRR, we directly support the financial maturity and competitiveness of the private sector," said Dragoș Pîslaru, Minister of Investments and European Projects. "The achievement of IT Genetics, which successfully finalised its listing on the AeRO market, is clear proof of how European funds transform local entrepreneurial potential into engines of growth."

"The listing of IT Genetics on the AeRO Market is a milestone both for the company and for Romania's tech entrepreneurial ecosystem," said Remus Vulpescu, CEO of the BVB. "The debut of IT Genetics represents an important milestone for the Group and the result of a journey built over nearly two decades of development," stated Liviu Sima and Ștefan Axinte, Co-founders of IT Genetics. "Throughout this period, IT Genetics has recorded profit in every year of operation."